The introduction of rapid monitoring of intraoperative parathyroid hormone (ioPTH)9 has allowed surgeons to assess whether the gland causing the primary hyperparathyroidism has been removed successfully, thereby reducing the risk of persistence. The gene discussed is PTH; the disease is primary hyperparathyroidism.